Ratings Genetec Technology

Equities

GENETEC

MYQ0104OO008

End-of-day quote BURSA MALAYSIA Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
2.24 ^MYR	+0.45%		-1.75%	-5.08%

05-29	Genetec Technology's Profit Jumps in March Quarter; Shares Rise 5%	MT
05-28	Genetec Technology Berhad Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Strengths

According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

Ratings chart - Surperformance

Sector: Industrial Machinery & Equipment

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
GENETEC TECHNOLOGY	-5.08%	368M	-	-
ATLAS COPCO AB	+14.78%	87.45B		A-
PARKER-HANNIFIN CORPORATION	+9.79%	65.02B		B
INGERSOLL RAND INC.	+17.46%	36.65B		B-
XYLEM INC.	+18.60%	32.88B		A
FORTIVE CORPORATION	+0.64%	26.09B		C+
FANUC CORPORATION	+6.32%	25.92B		B-
SANDVIK AB	-2.61%	25.14B		B+
DOVER CORPORATION	+17.32%	24.8B		B
TECHTRONIC INDUSTRIES CO. LTD.	-4.14%	20.94B		B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes